INS and type 2 diabetes mellitus: Shortly after the role of PPAR-γ in adipocyte differentiation was characterized, potent synthetic ligands of PPAR-γ (TZDs) were discovered (66) and subsequently used in the therapy of T2DM patients to improve insulin sensitivity (67).